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Abstract
Chronic exposure (24–72 hrs) of pancreatic islets to elevated glucose and fatty acid leads to glucolipoxicity characterized by
basal insulin hypersecretion and impaired glucose-stimulated insulin secretion (GSIS). Our aim was to determine the
mechanism for basal hypersecretion of insulin. We used mono-oleoyl-glycerol (MOG) as a tool to rapidly increase lipids in
isolated rat pancreatic ß-cells and in the clonal pancreatic ß-cell line INS-1 832/13. MOG (25–400 mM) stimulated basal
insulin secretion from ß-cells in a concentration dependent manner without increasing intracellular Ca
2+ or O2 consumption.
Like GSIS, MOG increased NAD(P)H and reactive oxygen species (ROS). The mitochondrial reductant ß-hydroxybutyrate (ß-
OHB) also increased the redox state and ROS production, while ROS scavengers abrogated secretion. Diazoxide (0.4 mM) did
not prevent the stimulatory effect of MOG, confirming that the effect was independent of the KATP-dependent pathway of
secretion. MOG was metabolized to glycerol and long-chain acyl-CoA (LC-CoA), whereas, acute oleate did not similarly
increase LC-CoA. Inhibition of diacylglycerol kinase (DGK) did not mimic the effect of MOG on insulin secretion, indicating
that MOG did not act primarily by inhibiting DGK. Inhibition of acyl-CoA synthetase (ACS) reduced the stimulatory effect of
MOG on basal insulin secretion by 30% indicating a role for LC-CoA. These data suggest that basal insulin secretion is
stimulated by increased ROS production, due to an increase in the mitochondrial redox state independent of the
established components of GSIS.
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Introduction
Obesity and diabetes have become increasing problems in the
world, a direction that began about 30 years ago and continues in
most countries. Diabetes develops in about 20% of obese
individuals, and it is not known what differentiates those who
develop diabetes from those who do not.
Obesity results from and sustains elevated circulating insulin.
Insulin hypersecretion mostly thought to result from insulin
resistance, has also been shown to cause insulin resistance as
demonstrated in rodents overexpressing the human insulin gene [1]
or treated with exogenous insulin [2], and by insulin infusion in
humans [3]. This suggests the possibility that insulin hypersecretion
may precede and drive the early stages of insulin resistance. The
timing of these two metabolic impairments may be so inextricably
linked that the order of events may never be elucidated, however,
this demonstrates the importance of understanding both processes.
Type 2 diabetes (T2D) occurs when hypersecretion fails to
compensate for insulin resistance. Hypersecretion at basal glucose
is an associated problem in that it reduces the effectiveness of
stimulatory glucose. The mechanism for basal hypersecretion of
insulin has received little attention.
High insulin secretion in the absence of stimulatory glucose can
be caused in vivo by high fat feeding and mimicked in vitro by
prolonged exposure to fatty acids (FA) [4,5]. Although FA acutely
enhance GSIS [6], chronic exposure of ß-cells to elevated levels of
FA and glucose, designated as glucolipoxicity (GL), is a condition
that mimics early type 2 diabetes in that it is characterized by
increased basal insulin release and impaired GSIS [4].
In ß-cells, the toxic effects of lipids and glucose, alone or together
have recently received abundant attention [7,8,9]. FA are non-toxic
essential nutrients that circulate in the blood at levels of 0.1 to
1.0 mMcomplexedto albumin. The termsglucotoxicity,lipotoxicity
and glucolipotoxicity have no generally accepted definition. In
different studies, they refer to different combinations and concen-
trations of glucose and FA, FA chain length, FA saturation, and FA
to albumin complexes [10,11,12,13]. Clearly, excessive and non-
physiological levels of glucose and FA, or saturated FA alone, induce
ß-cell damage ultimately leading to apoptosis and cell death.
Combinations that include physiological levels of mono-unsaturated
FA, alone or together with saturated FA, and bound to albumin in
appropriate ratio are not toxic to cells but do stimulate insulin
secretion. This also occurs in vivo with a nutrient rich diet or in
various models of obesity and diabetes. In this study we refer to
extendedexposuretophysiologicalconcentrations of FA and glucose
as glucolipoxity as originally proposed by Prentki and Corkey [14].
Mono- and diglycerides are commonly added to commercial
food products in small quantities. They act as emulsifiers, helping
to mix ingredients such as oil and water that would not otherwise
blend well, and as preservatives. They are often found in bakery
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whipped toppings, margarine, and confections. One special
mono-acyl-glycerol, 2-arachidonoyl-glycerol, is a full agonist of
the cannabinoid receptors and thus classified as an endocannabi-
noid [15]. In this study, only MOG will be used, as it acutely
stimulates insulin secretion and can be compared to oleate that
does not stimulate basal insulin secretion. Mono-acyl-glycerides
may be ingested or formed biochemically in the gut by release of
FA from the 1 and 3 positions of triglyceride [16] and in cells via
release of FA from diacylglycerol (DG), by diacylglycerol lipase or
hormone sensitive lipase, and broken down by mono-acylglycerol
lipase (MGL). Zawalich and co-workers documented that low
concentrations (25–50 mM) of MOG enhance insulin secretion
stimulated by a variety of agonists [17,18] and 100 mM increased
secretion at substimulatory glucose [17], an effect they attributed
to inhibition of diacylglycerol kinase (DGK).
The insulin secretory process involves a combination of a Ca
2+-
dependent triggering pathway and an amplification pathway that
requires a permissive level of Ca
2+. Intracellular lipids have gained
attention as an important part of the amplification pathway and as
likely candidates to provide aberrant signals leading to impaired
insulin secretion [4,5,19,20]. The hypothesis being evaluated in this
study is that if glucose and FA lead to accumulation of intracellular
mediators resulting in time-dependent impaired insulin release,
MOG may acutely elevate a similar set of mediators at basal glucose.
The advantage of the rapid MOG effect, supported by our data,
is that GL-induced metabolic changes could be mimicked in a very
short time without altered gene expression that occurs with the
longer incubations (1–2 days) needed by elevated glucose and FA.
Our data suggest three MOG-induced mediators of insulin
secretion: cellular redox state reflected in the NAD(P)H:NAD(P)
ratio (redox), ROS and LC-CoA. Insight into these mediators
could provide new targets to ameliorate early insulin hypersecre-
tion and later impaired ß-cell function.
Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. The protocol was
approved bytheCommitteeontheEthicsofAnimalExperimentsof
the Boston University Medical Center (Boston University Medical
Center Animal Welfare Assurance: A-3316-01).
Islets
Islets were isolated from male Sprague-Dawley rats (150–250 g)
[21]. Briefly, 15 ml of Hank’s balanced salt solution containing
10 mM Hepes (pH 7.4), 3 mM glucose (HBSS) and 0.2 mg/ml
collagenase P (2.3 units/mg) (Roche, Indianapolis, IN) was infused
into the pancreas through the bile duct. The inflated pancreas was
then excised and incubated for 20 min at 37uC. The digested
pancreas was then shaken to release the islets, which were washed
with HBSS supplemented with 0.1% BSA and further isolated by
centrifugation through a Histopaque gradient (Sigma, St. Louis,
MO) [21]. Human islets were obtained from the National Disease
Research Interchange (www. ndriresource.org). Isolated islets were
cultured overnight in RPMI 1640 containing 10% FBS, 50 IU/ml
penicillin and 50 mg/ml streptomycin. Islets were dissociated in
HBSS containing 20 mM Hepes, 3 mM EGTA, 3 mM glucose,
2.5% BSA and 0.001% trypsin at 37uC for 2.5 min [21,22] and
attached to cover slips with CELL-TAK or plated in multiwell
culture plates mixed with matrigel (1:1 ratio) as per product
instructions (BD Biosciences, Bedford, MA).
INS-1 832/13 cells
INS-1 832/13 cells [23] were cultured in RPMI media as above
with the addition of 10 mM Hepes, 1 mM pyruvate and 50 mMß -
mercaptoethanol [4]. ß-Mercaptoethanol was routinely added to
the RPMI media just before use.
Lipid preparations
MOG was prepared as a DMSO stock, which was diluted into
modified Krebs-Ringer bicarbonate buffer (KRB) at 37uCw h i l e
vortexing. Oleate was dissolved in DMSO and complexed to either
FBS (Invitrogen, Carlsbad, CA) or fatty acid free BSA (4:1 molar ratio)
at 56uC while vortexing. Final concentration of DMSO was 0.1%.
Perifusion
Groups of 60 islets were placed in a column on top of a 1 cm
bed of cytodex 3 beads and perifused at 37uC at a rate of 0.3 ml/
min with KRB containing 3 mM glucose for 30 min [23]. After
30 min samples were collected at 15 sec intervals. Perifusate was
changed as indicated in figure legends. KRB contained (in mM)
119 NaCl, 4.6 KCl, 5 NaHCO3, 2 CaCl2, 1 MgSO4, 0.15
Na2HPO4, 0.4 KH2PO4, 20 HEPES, 0.05% BSA, pH 7.4.
Insulin secretion
Insulin secretion was measured in INS-1 cells grown for at least
3 days to approximately 0.25 million cells/well in 48-well plates.
INS-1 cells were preincubated with RPMI containing 2 mM
glucose without serum for 2 hrs prior to KRB incubation. INS-1
cells and dissociated islets in matrigel (4–5 thousand cells/well)
were preincubated in low glucose KRB at 37uC for 30–45 min.
They were then cooled on ice and cold KRB with test compounds
was added. Cells were incubated for 30–60 min at 37uC, cooled
and sampled for insulin release. Insulin was measured by
radioimmunoassay (Millipore, Billerica, MA).
Ca
2+ determination
Intracellular Ca
2+ was measured in cells using fura-2, AM
(Invitrogen, Carlsbad, CA). Single cells from dissociated rat
pancreatic islets were attached to glass bottom 35 mm dishes
(MatTek, Ashland, MA) with CELL-TAK. The glass bottom
dishes were mounted onto the stage of a Zeiss IM-35 fluorescence
microscope and Ca
2+ was monitored continuously, using a time-
sharing fluorometer with output to a cooled CCD camera
(IONOPTIX Corp., Boston, MA) [24].
ROS determination
Cells were loaded for 45 min with 8 mM 5-(and-6)-chloro-
methyl-29,79-dichlorodihydrofluorescein diacetate, acetyl ester
(CM-H2DCFDA) suspended in KRB containing 0.1% pleuronic
acid, followed by two 15 min washes in KRB. DCF fluorescence
was then measured over time using a TECAN M 1000 plate
reader (Mannedorf, Switzerland) (excitation at 488 nm; emission
at 520 nm). For HyPer measurements, freshly isolated islets were
dissociated and transduced for 4 hrs with 200 hyper-encoding
adenoviral particles per cell as determined by AdEasy viral titer kit
(Stratagene, La Jolla, CA) [25]. Transduced Islet cells were mixed
with matrigel and plated in 4 quadrant CellView Dishes (Greinier
Bio-One, Monroe, NC) for 72 hrs and imaged using a Zeiss LSM
710 LIVE fluorescence microscope using excitation wavelengths of
488 and 405 while collecting emissions with a long pass 495 nm
filter with output to a linear CCD array. Images were acquired
using Zeiss ZEN and analyzed with the ‘‘ImageJ for Microscopy’’
Bundle [26]. Islets were maintained at 37uC during the
measurements using a Zeiss incubation chamber.
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Islets were placed under matrigel on a 4 quadrant CellView
Dish and imaged using a Zeiss LSM 710 DUO fluorescence
microscope using two photon excitation wavelength 720 nm and
emission wavelengths of 371–580 nm [27]. Conditions and
analysis tools were similar to HyPer experiments above.
Oxygen Consumption
Oxygen consumption was measured at 37uC from INS-1 cells
grown in Seahorse V.7 multiwell culture plates with a companion
extracellular O2 flux sensor using the Seahorse XF24 analyzer
(Seahorse Bioscience, Billerica, MA). Cells were seeded at a
density of 50,000 cells/well and cultured for 2 days. Cells were
incubated as for insulin secretion and O2 consumption measure-
ments were performed in KRB.
LC-CoA and free CoA
INS-1 cells were grown to approximately 1 million cells/well in
12-well plates and incubated as for insulin release. Cells were
exposed to 0.2 mM MOG for up to 30 min and media sampled
for insulin release. Cells were then quick frozen in liquid nitrogen
and stored at 280uC until processed for LC-CoA analysis. Frozen
cells were thawed on ice in 1% trichloroacetic acid containing
3.75 mM DTT. Trichloroacetic acid extracted from the precip-
itated cells was centrifuged (12,0006 g, 3 min), washed 3 times
with equal volumes of ether and assayed for total free CoA. The
precipitated cells were washed with cold water and hydrolyzed in
3.75 mM K2HPO4 buffer pH 11.5 at 55uC for 10 min to produce
free CoA from membrane associated LC-CoA. Free CoA was then
measured enzymatically making use of the a-ketoglutarate
dehydrogenase reaction as described previously [28]. Standard
curves were produced from varying concentrations of both ether
washed free CoA and hydrolyzed LC-CoA in order to account for
recovery during sample processing. NADH produced in the assay
was then detected by luminescence using NADH-dependent
bacterial luciferase as detailed by Peyot et.al. [29].
Glycerol
Glycerol was measured enzymatically from the same final
incubation solutions removed from INS-1 cells to monitor MOG-
induced insulin release described above. NADH produced in the
assay was then detected by luminescence [29].
Statistical analysis
Statistical analysis was performed using Student’s t test where
indicated. Values are plotted as averages +/2 SEM.
Materials
Insulin radioimmunoassay kit was from Millipore (Billerica,
MA). Fura and DCFDA were from Invitrogen (Carlsbad, CA).
Triacsin C was from ENZO Life Sciences (Farmingdale, NY).
MOG, DG Kinase inhibitor and all other chemicals were from
Sigma (St. Louis, MO). Enzymes for glycerol and LC-CoA
analysis were from Sigma or Roche (Mannheim, Germany).
Hyper construct was from Axxora LLC. (San Diego, CA).
Results
The common technique to create insulin resistance in vivo is to
feed a high fat-high carbohydrate diet to model animals. The ß-
cell malfunction that is induced in this way can also be reproduced
in vitro by prolonged incubation in media containing high glucose
and added FA. Fig. 1A illustrates the consequences of treatment of
INS-1 832/13 cells for 18 hours in media containing 11 mM
glucose and either 0.16 mM or 0.3 mM oleate complexed to FBS.
As has been shown by others [4,30], this results in a 2-fold increase
in secretion at 2 mM glucose (basal) with responsiveness to
stimulatory 12 mM glucose diminished by 50 percent. The
increase in basal insulin secretion occurred at a lower FA
concentration than did the change in glucose-stimulated insulin
release. This robust stimulation of basal secretion does not occur
acutely but requires several hours of incubation and may involve
altered expression of numerous metabolically sensitive proteins
[31,32]. Thus, it is not clear whether this hypersecretion requires
altered gene expression or a time-dependent generation of an
Figure 1. MOG mimicked long-term exposure to glucose and
FA by stimulating basal insulin secretion from pancreatic islet
cells. A. Long-term exposure to 11 mM glucose and either 0.16 mM or
0.3 mM oleate complexed to FBS (FA) increased basal (2 mM glucose,
white bars) and decreased glucose-stimulated insulin release (12 mM
glucose, shaded bars) from INS-1 832/13 cells. MOG stimulated basal
insulin secretion from dissociated rat islets in a concentration-
dependent manner (25–400 mM) (B). C. Perifusion of rat islets
demonstrated the pattern of MOG-stimulated basal insulin secretion.
Arrow indicates addition of 200 mM MOG to 3 mM glucose. A and B.
n=12 from 3 separate experiments. C. Representative of 3 separate
experiments. A and B, *p,0.005 compared to control.
doi:10.1371/journal.pone.0030200.g001
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previously [33].
To determine whether hypersecretion could be caused acutely,
we assessed the effect of several lipid molecules and metabolites on
basal secretion. We found a useful tool in MOG that had a
concentration dependent ability to increase insulin secretion by
isolated rat pancreatic islets (Fig. 1B) at non-stimulatory glucose.
Perifusion studies in isolated islets indicated that this effect
consisted of a rapid increase followed by a recovery to a new
sustained elevated basal level of secretion (Fig. 1C). Similar
responses were obtained in INS-1 cells (data not shown).
Fuel-induced insulin secretion involves an elevation in cytosolic
Ca
2+, presumably due to closure of the KATP-channel, depolar-
ization and opening of voltage-gated Ca
2+ channels. Diazoxide,
used to prevent closure of the KATP-channels, did not diminish
MOG-induced secretion while completely blocking GSIS in INS-1
cells (Fig. 2A) and dissociated rat islets (Fig. 2B). The combination
of MOG and stimulatory glucose increased insulin secretion more
than either alone. Diazoxide in this case reduced insulin secretion
stimulated by glucose in the prescence of MOG to the level of
MOG-stimulated basal release (Fig. 2), further indicating that
MOG-stimulated insulin secretion was independent of the KATP-
channel.
Consistent with a KATP-channel-independent mode of signal-
ing, there was no change in cytosolic free Ca
2+ in response to the
acute addition of MOG to dissociated ß-cells incubated at basal
glucose conditions (Fig. 3A).
Another attribute of GSIS and secretion induced by other
stimulatory fuels is an increase in O2 consumption. Although we
confirmed that stimulatory glucose increased respiration as
expected, MOG did not increase O2 consumption at 2 mM
glucose (Fig. 3B) or increase the stimulated respiration that
accompanied GSIS (Fig. 3C). These data indicated that MOG-
induced insulin secretion was independent of the consensus
signaling pathway involving metabolite-induced stimulation of
respiration with increased production of ATP, closure of KATP-
channels and entry of Ca
2+ [34].
Protein kinase C involvement in insulin secretion has been
documented previously [24]. An earlier study considered MOG an
inhibitor of DGK and concluded that its ability to increase insulin
secretion was due to this inhibition and the resulting signals
generated by accumulated diacylglycerol (DG) [17,18]. To
evaluate this possibility we used a specific inhibitor of DGK,
R59949, and found that although it stimulated GSIS at 0.25 mM,
it markedly inhibited GSIS at 10 mM, and had little effect on basal
secretion under conditions where MOG potently stimulated
insulin secretion (Fig. 4). This indicated that simply inhibiting
DGK is not sufficient to fully stimulate insulin secretion and
suggested that MOG must generate other signals.
The assessment of MOG as a potential lipid secretagogue was
based on abundant evidence that lipids can generate important
signals in ß-cells via their metabolism. To determine whether
MOG was metabolized we assessed the temporal relationship
between insulin secretion (Fig. 5A) and the products of MOG
metabolism, glycerol (Fig. 5B), long-chain acyl-CoA (LC-CoA)
(Fig. 5C) and the ratio of LC-CoA:CoASH (Fig. 5D) in INS-1 cells.
Oleate that does not stimulate insulin secretion acutely at basal
glucose had significantly less effect to elevate LC-CoA and the LC-
CoA:CoASH ratio than MOG (Fig. 5D). Triacsin C, an inhibitor
of ACS activity [35], decreased the stimulatory effect of MOG on
basal insulin secretion by 30% (Fig. 5E). The possibility that
MOG-induced insulin secretion was mediated by LC-CoA
(Fig. 5C) or the LC-CoA:CoASH ratio (Fig. 5D) is consistent
with these data. We have previously shown that LC-CoA or a
product formed from LC-CoA directly stimulates exocytosis [36].
Glycerol and FFA added in combination to cells does not induce
an increase in basal secretion [10,11], suggesting intracellular
metabolism of MOG is required. These data are consistent with
the concept that a metabolic product formed from MOG could
cause hypersecretion.
The ability of stimulatory glucose and other stimulatory fuels
such as ß-OHB to increase redox is well established [21]. ß-OHB
is readily transported into the mitochondria where ß-OHB
dehydrogenase converts it to acetoacetate using NAD and
producing NADH, as we have shown previously [37]. Fig. 6
shows that indeed MOG, like ß-OHB, increased the redox state
rapidly and significantly in islets (Fig. 6 A and B). It has been
established that ROS generation is dependent on both the
mitochondrial redox state and mitochondrial membrane potential
(D¥) [38].
We next evaluated the possibility that the increased mitochon-
drial redox state could increase insulin secretion via increased
ROS generation. Fig. 7 shows that ß-OHB (at high non-
physiological concentrations) stimulated insulin secretion at basal
glucose like 100 mM MOG or 8 mM glucose (Fig. 7A). Treatment
with the ROS scavenger N-acetyl L-cysteine (NAC) prevented the
elevation in basal secretion (Fig. 7A) in a concentration dependent
manner (Fig. 7B), implying a ROS-dependent mechanism.
Figure 2. MOG-stimulated basal insulin secretion was inde-
pendent of the KATP channel. MOG (0.2 mM) stimulated basal
(2 mM glucose) insulin release (white bars) was not prevented by
addition of 0.4 mM diazoxide (black bars) in both INS-1 (A) and
dissociated rat islet cells (B). MOG enhanced glucose-stimulated insulin
release in both INS-1 (12 mM glucose) and islet cells (15 mM glucose)
(white bars). Diazoxide blocked glucose-stimulated insulin release with
and without MOG (black bars), revealing a sustained increase of basal
secretion in the presence of MOG. A. n=9 in 3 separate experiments. B.
n=6 from duplicate experiments. * p,0.005.
doi:10.1371/journal.pone.0030200.g002
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and glucose induced secretion (Fig. 7C), presumably by scavenging
ROS. The increase in insulin secretion stimulated by the
combination of ß-OHB and MOG added together was not
significantly different to the sum of their individual effects (Fig. 7D).
This was also true for the combination of ß-OHB and 8 mM
glucose (data not shown). This is in contrast to the enhanced effects
of MOG in the presence of stimulatory glucose (Fig. 2).
We previously demonstrated that provision of either exogenous
H2O2 or diethyl maleate, which raises intracellular H2O2 levels,
stimulated insulin secretion [39]. In addition, exogenous antiox-
idants such as cell permeable catalase and NAC inhibited GSIS
and intracellular H2O2 accumulation [39]. More recently
inhibition of isoprenylcysteine carboxyl methyltransferase activity
in INS-1 832/13 cells was shown to inhibit both glucose-induced
ROS production and insulin secretion [40]. In Fig. 8 we show that
MOG and ß-OHB, like glucose, generated ROS in INS-1 cells
(Fig. 8A and B). We also document that MOG- and ß-OHB-
induced ROS in dissociated rat islets (Fig. 8C, D and E). The
increase in ROS occurred rapidly with MOG compared to ß-
OHB as measured by increased DCF fluorescence (8A and B) and
increased Hyper fluorescence ratio (Fig. 8D and E).
Discussion
Using MOG and the mitochondrial reductant ß-OHB, we have
identified ROS as a novel obligatory messenger for insulin
secretion, independent of the consensus pathway of GSIS that
involves increased respiration, KATP channel closure, and elevated
cytosolic Ca
2+. MOG rapidly and robustly mimicked the effects of
long-term exposure to elevated FA and glucose and the condition
described as glucolipoxity, manifested as basal insulin hypersecre-
tion.
The possible novel signals for insulin secretion derived from
MOG metabolism include lipid products such as LC-CoA (34) and
DG [17,18], ROS [39], action through membrane receptors such
Figure 3. The effect of MOG to stimulate basal insulin
secretion was independent of changes in cytosolic Ca
2+ and
oxygen consumption. A. 200 mM MOG did not increase cytosolic
Ca
2+ in dissociated rat islet cells. Arrows indicate addition of 11 mM
glucose (black trace) and 200 mM MOG (gray trace). B. 200 mM MOG
(white squares) did not affect basal O2 consumption in INS-1 cells.
Incubation with and without MOG started 30 min prior to O2
consumption measurements. Arrows indicate addition of 5 mM
oligomycin (O) to inhibit respiration and 100 mM dinitrophenol (DNP)
to stimulate maximal respiration. C. 200 mM MOG did not affect
glucose-stimulated O2 consumption in INS-1 cells. Arrow indicates
addition of 2 mM glucose (black diamonds) and 12 mM glucose alone
(white squares) or with 200 mM MOG (white triangles). A. Average
signal from more than 10 cells per condition. Representative of 3
separate measurements. B and C. n=4 from single experiment
repeated three times.
doi:10.1371/journal.pone.0030200.g003
Figure 4. The DG kinase inhibitor R59949, failed to mimic the
effects of MOG to stimulate insulin secretion from INS-1 ß-cells
at 2 mM glucose. 0.2 mM MOG (hatched bar) increased basal (2 mM
glucose) insulin secretion from INS-1 cells 2.5-fold while 12 mM glucose
resulted in a 3.5-fold increase (first black bar). The effect of the DG
kinase inhibitor R59949 to stimulate basal insulin secretion (white bars)
was small and inconsistent over the concentration range tested (0.25–
10 mM) compared to the MOG-stimulated increase in basal release
(hatched bar). R59949 increased glucose-stimulated insulin release 2-
fold at low concentration (0.25 mM) with higher concentrations (1–
10 mM) having no stimulatory effect compared to the control (black
bars). N=9 from 3 separate experiments. *p,0.05; **p,0.005
compared to control basal value. #p,0.005 compared to high glucose
control.
doi:10.1371/journal.pone.0030200.g004
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Inhibition ofLC-CoAsynthetasewithtriacsinCreducedthestimulatoryeffectofMOGonbasal(2 mMglucose) insulin secretion (E). A.
200 mM MOG increased basal (2 mM glucose) insulin secretion from INS-1 cells in a time-dependent manner. Glycerol release (B) and LC-CoA formation
(C) were increased over time from the same cells. D. 200 mM MOG increased LC-CoA: free CoASH ratio to a greater extent than 200 mM oleic acid bound
(4:1 molar ratio) to BSA (FA) compared to the 2 mM glucose control after 1 hr incubation. E. Triacsin C (96 mM) inhibited insulin secretion stimulated by
100 mM MOG by 30% without affecting basal (2 mM glucose) insulin secretion from INS-1 cells. Triacsin C was included in both the preincubation and
test conditions. A and B p,0.005 for all. C and E. *p,0.05 n=9 to 12 from 3–4 different passages of cells. D. *p,0.05 n=4 from single experiment.
doi:10.1371/journal.pone.0030200.g005
Figure 6. MOG and ß-OHB increased REDOX state in rat pancreatic islets. A. NADH fluorescence was increased in rat islets after addition, at
0 minutes, of 200 mM MOG (dashed line) or 10 mM ß-OHB (solid line) compared to basal 3 mM glucose (circles). Data plotted as a 3 point moving
average. B. Area under curve from point of addition to four minutes. Average of 48–55 islets from 3 separate animals. *p,0.05 ***p,0.0001.
doi:10.1371/journal.pone.0030200.g006
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CoA. We can rule out non-specific cell damage because islets
treated with MOG recovered fully following overnight incubation
in normal media (data not shown) and exhibited normal
respiratory responses to glucose (Fig. 3C). The fact that MOG
metabolism gave rise to increases in glycerol and LC-CoA
exhibiting different time-courses was unexpected (Fig. 5 B and
C). It may be that LC-CoA is rapidly esterified to other lipid
moieties inside the cell while the lack of glycerol kinase in the ß-cell
[42] precludes this re-esterification to glycerol itself. Thus it is
predicted that MOG gives rise to a host of other lipid moieties in
the ß-cell whose identification is beyond the scope of this study. A
role for LC-CoA, either directly or indirectly through lipid
esterification or protein acylation, is indicated as a result of the
partial inhibition of MOG-induced basal insulin secretion using
triacsin C, an acyl CoA synthetase inhibitor. Since it was possible
to block the stimulatory effects of MOG, ß-OHB and glucose with
the ROS scavengers NAC and resveratrol, we concluded that
ROS was the obligatory signal, whereas the other putative
mediators may be secondary. It is interesting that 200 mM
MOG stimulates a greater production of ROS in pancreatic ß-
cells than 10 mM ß-OHB. The metabolism of MOG results in a
global increase in LC-CoA in the cell leading presumably to other
lipid moieties while ß-OHB is metabolized solely in the
mitochondria of these cells. The contributions of cytosolic versus
mitochondrial sources of ROS measured as a result of MOG and
other nutrient metabolism is under investigation.
It is interesting to speculate why FA addition requires much
more time to cause basal hypersecretion than MOG. Several
possibilities may be considered. First, there is control of FA access
to the cell by albumin and acyl CoA synthases. High physiological
concentrations of albumin prevent rapid uptake of large quantities
of FA in excess of the ability of acyl CoA synthases to activate
them. This idea is supported by our previous studies showing that
only a small increase in LC-CoA occurs in response to FA acutely
but LC-CoA increases following overnight incubation [33,43].
Second, there are two possible pathways for MOG metabolism:
via MGL that generates FA and glycerol and via monoacylglycerol
acyl transferase (MGAT) to generate DG. The relative roles of
MGL and MGAT have not been assessed in the ß-cell. However,
both may occur and the implications of each may differ: DG
acting through a PKC signaling cascade and LC-CoA directly
stimulating exocytosis [36] as well as acting on a variety of steps
involved with energy metabolism.
We have previously demonstrated that LC-CoA stimulates
exocytosis at low Ca
2+ concentrations [36] and activates the KATP
channel [33,44,45,46,47] leading to impaired Ca
2+ signaling [48].
Interesting recent studies have documented reduced ß-cell
Figure 7. Scavenging ROS with NAC (A, B) or Resveratrol (C) blocked MOG, ß-OHB and glucose-stimulated insulin secretion. The
effect of MOG to stimulate basal (2 mM glucose) insulin secretion was not enhanced by the prescence of ß-OHB (D). A. 3 mM NAC
(black bars) inhibited 10 mM ß-OHB-, 100 mM MOG- and 8 mM glucose-stimulated insulin secretion from INS-1 cells. B. 10 mM ß-OHB-stimulated
insulin secretion was inhibited by NAC in a concentration-dependent manner (0.3–3 mM). C. 100 mM resveratrol (black bars) inhibited 10 mM ß-OHB-,
100 mM MOG- and 8 mM glucose-stimulated insulin secretion from INS-1 cells. D. The increase in insulin secretion stimulated by addition of ß-OHB
and MOG together was equal to the sum of their individual effects. A–D. n=9–12 per condition from 3 separate experiments. * p,0.005 compared to
2G control. A, C. # p,0.005 compared to its own control. B. + p,0.005 compared to no NAC. D. # p,0.005 compared to ß-OHB or MOG added
separately.
doi:10.1371/journal.pone.0030200.g007
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in intact pancreatic ß-cells [49] and modulation of ß-cell Na
+-Ca
2+
exchangers by LC-CoA [49,50]. In addition, LC-CoA has been
shown to overcome inhibition of carnitine palmitoyl transferase-1
by malonyl CoA [51], and inhibit the adenine nucleotide
translocase [52,53], both of which are important in stimulation
of glucose-induced insulin secretion. Thus, increased LC-CoA
after MOG exposure is a potential candidate for mediating some
of the observed aberrant effects on secretion. The effect of triacsin
C to partially block the stimulation of basal insulin secretion by
MOG provides supporting evidence for a role for LC-CoA in the
development of lipid-induced basal hypersecretion.
It is not clear whether these effects of MOG are of physiological
importance. MOG caused a twofold increase in basal insulin
secretion at concentrations as low as 25 mM (Fig. 1). Monoglyc-
erides are normal products of TG degradation by tissue-associated
lipoprotein lipase [54] and in the intestine where a remnant
molecule of 2-monoglyceride is transported into the enterocytes
with two FA liberated from TG. In the past 30 years, mono-
glycerides have been increasingly added to foods as emulsifiers or
preservatives. However, relevance to human physiology and the
obesity and diabetes epidemic cannot be implied, as circulating
concentrations were not found and may be considerably lower
than concentrations tested. It is possible, however, that long term
exposure to low concentrations of MOG may elevate basal insulin
secretion like long term exposure to GL.
The key findings from these data are that basal hypersecretion
can be induced by exposure to MOG in the absence of elevated
glucose without increasing cytosolic Ca
2+ or O2 consumption in
human islets, rodent islets and INS-1 cells. It should be noted that
an increase in redox without an increase in respiration implies
excess mitochondrial substrate supply (NADH) that leads to
increased ROS production. During the same interval we have
shown that MOG was metabolized, increased the redox state and
generated ROS. Scavenging ROS prevented all of the acute
MOG effects on secretion indicating that ROS was an obligatory
signal for insulin secretion. Mimicking the MOG-induced redox
changes with ß-OHB or inducing ROS changes by other means
[39] also increased insulin secretion. Thus, ROS may act
synergistically with other putative signals such as LC-CoA, Ca
2+
and DG but basal hypersecretion does not appear to occur without
the ROS signal.
Figure 8. MOG and ß-OHB generated ROS in insulin secreting cells. A. Both 200 mM MOG (squares) and 10 mM ß-OHB (triangles) increased
ROS in INS-1 cells compared to basal (2 mM glucose) alone (circles). B. Area under curve of panel A. 200 mM MOG increased ROS generation in
dissociated rat islets (C) compared to 3 mM glucose controls as measured with DCF fluorescence. D. 200 mM MOG (squares) and 10 mM ß-OHB
(triangles) increased ROS generation in dissociated islet cells expressing the cytosolic HyPer protein compared to the basal (2 mM glucose) control as
measured by changes in fluorescence ratio. E. Area under curve of D. A, B. n=16 from 4 separate passages of cells. C. Results are typical of three
separate experiments. D, E. Average of 14–33 cells from 3 separate animals. (A–C). ROS monitored for 1 hr in cells loaded with CM-H2DCFA using a
Tecan fluorescence platereader. (D–E). HyPer fluorescence ratio in dissociated islet cells monitored using a Zeiss 710 LIVE fluorescence microscope at
206magnification. B and E, * p,0.005% compared to basal.
doi:10.1371/journal.pone.0030200.g008
Monoglyceride Induces Basal Insulin Secretion
PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e30200ROS may also play a role in elevated basal insulin secretion
resulting from more traditional means of inducing GL. In this
regard gene expression profiling of clonal pancreatic ß-cells
cultured (24–72 hrs) under conditions of elevated glucose and
FA has been performed in the mouse cell line MIN6 using oleate
[55] and in INS-1 832/13 using palmitate [56]. Both studies
revealed a host of changes in metabolic enzymes affecting lipid
handling. Both studies demonstrated an increase in ROS
production and impaired insulin secretion in that basal secretion
was elevated and glucose-stimulated insulin release was inhibited.
Investigators using the MIN6 model also used NAC (1 mM) to
scavenge ROS. In this case they were able to reduce by 70% the
number of oleate-induced downregulated genes. NAC was
reported not to alter insulin secretion from the oleate treated
cells, however insulin content of cells treated with NAC was
increased 2-fold compared to oleate alone. NAC therefore could
be said to have increased insulin exocytosis when analyzed as
insulin release as a percent of content.
The rapidity of MOG effects may provide a novel model to
examine the role of elevated lipids on insulin secretion without
concern for the alterations in gene expression that may occur over
the hours required to achieve similar elevations in secretion by
GL.
Furthermore, the acute elevation of intracellular lipids by MOG
implied by the large increase in LC-CoA, independent of
stimulatory glucose, may provide a useful model to study the role
of lipid signaling during insulin resistance and may lead to
identification of important lipid and protein signals that modulate
secretion in the ß-cell.
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